Keywords: arimidex, gets, 6-month, patent, extension, anglo-swedish, drug

Arimidex gets 6-month US patent extension

Article | 10 December 2007

Print This

Anglo-Swedish drug major AstraZeneca says that the US Food and Drug Administration has granted an additional six-month pediatric period of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in